GBM Awareness Day Is About More Than Awareness

Every July, Glioblastoma Awareness Day asks people to look toward a disease most families never expect to learn about.

That matters.

Glioblastoma is aggressive. It is frightening. It changes language, movement, memory, personality, independence, work, parenting, marriage, money, and time. It asks families to make hard decisions quickly, often before they have even caught up to the first sentence of the diagnosis.

So yes, awareness matters.

But awareness cannot be where we stop.

Because once a family hears the word glioblastoma, the work does not end when the appointment ends. In many ways, that is where it begins.

They go home.

They open the portal.
They reread the MRI report.
They try to remember what the neurosurgeon said.
They search terms they have never seen before: MGMT, IDH, unmethylated, subtotal resection, pseudoprogression, radiation necrosis, recurrence, Optune, bevacizumab, clinical trial eligibility.

They wonder if the treatment plan is enough.

They wonder if they should get a second opinion.

They wonder whether confusion is from swelling, medication, radiation, lack of sleep, or the tumor itself.

They wonder if they should call the doctor, go to the emergency room, wait until morning, or stop panicking.

And often, someone in the family quietly becomes the person who has to hold all of it.

The caregiver becomes the keeper of the timeline. The medication list. The symptoms. The scan history. The questions for the next appointment. The insurance calls. The clinical trial tabs. The family updates. The hope. The dread.

This is the part of GBM that is hardest to see from the outside.

The disease is not only happening in the hospital. It is happening in kitchens, bedrooms, cars, waiting rooms, text threads, and late-night searches. It is happening when someone is trying to help a parent shower safely. When a spouse is watching for seizures. When an adult child is reading a trial page and realizing the nearest site is two states away. When a family is told hospice might be appropriate, but the person they love is still eating breakfast and asking about the day.

That gap between clinical care and real life is where Ember has spent the past year.

In our first year, families created 4,028 de-identified GBM conversation threads across more than 50 countries, generating nearly 49,000 total messages between users and the Companion.

The scale is important. But the pattern is more important.

Families are not only asking for information.

They are asking for interpretation.

They are asking what a scan phrase might mean. Whether a symptom sounds urgent. How to think about treatment options. How to prepare for radiation. How to find a clinical trial. How to understand eligibility. What to ask the doctor. What hospice means. What the end might look like. How to keep going when the person they love is changing in front of them.

These are not abstract educational needs. They are decision moments.

A question about an MRI is often really a question about whether the treatment is still working.

A question about steroids is often really a question about whether the person is getting worse.

A question about a clinical trial is often really a question about whether there is still time.

A question about caregiving is often really a question about whether anyone sees what this is costing.

This is what GBM Awareness Day should make visible.

Not just the biology of the disease.

The family system around it.

The spouse who becomes a nurse without training.
The daughter who manages appointments from another state.
The parent caring for an adult child.
The patient trying to stay involved while language or memory starts slipping.
The caregiver who does not know whether to be hopeful, realistic, practical, devastated, or all of it at once.

Awareness should include them.

It should include the questions families ask after the appointment. The fear they carry into every scan. The impossible speed of decisions. The way clinical trial access depends not only on science, but on geography, money, timing, transportation, eligibility, and whether a caregiver can hold the whole plan together.

It should include the long stretch between “there is a treatment plan” and “we know how to live with this.”

At Ember, we believe serious illness support has to move closer to that real moment.

Closer to the caregiver.
Closer to the scan report.
Closer to the symptom that changed overnight.
Closer to the trial search.
Closer to the family trying to understand what the doctor said after they got home and everyone else went back to their lives.

That is not a replacement for the clinical team. It is not a shortcut around medicine. It is support for the space where families are already doing the work, often alone.

This GBM Awareness Day, we are thinking about every family who has heard the words glioblastoma and then had to become fluent in a world they never wanted to enter.

We are thinking about the people still searching at midnight.

The people waiting for scan results.

The people trying to decide whether to pursue another treatment, another trial, another opinion, another day.

The people caring for someone they love while losing parts of them in real time.

Awareness should mean seeing all of that.

And then building support that actually meets families there.